Late-onset blebitis/endophthalmitis: Incidence and outcomes with mitomycin C

Optometry and Vision Science

Volumn 81, Issue 7, 2004, Pages 499-504

  Muckley, Elizabeth Draper ^a   Lehrer, Richard A ^b  

^a Northeast Ohio Eye Surgeons   (United States)

^b NONE

Author keywords

Blebitis; Endophthalmitis; Late onset; Mitomycin C; Outcomes

Indexed keywords

ANTIBIOTICS; DATABASE SYSTEMS; SURGERY;

ENDOPHTHALMITIS; FILTERING SURGERY; INTRAOCULAR PRESSURE;

VISION;

CIPROFLOXACIN; MITOMYCIN C; PREDNISOLONE; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ADULT; AGED; ANTIBIOTIC THERAPY; CATARACT EXTRACTION; EARLY DIAGNOSIS; ENDOPHTHALMITIS; FEMALE; FILTERING OPERATION; HOSPITALIZATION; HUMAN; INTRAOCULAR PRESSURE; LENS IMPLANTATION; MAJOR CLINICAL STUDY; MALE; OPERATION DURATION; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; REVIEW; STAPHYLOCOCCUS EPIDERMIDIS; STREPTOCOCCUS PNEUMONIAE; TRABECULECTOMY; VISION;

AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; ANTIMETABOLITES, ANTINEOPLASTIC; CATARACT EXTRACTION; COMBINED MODALITY THERAPY; ENDOPHTHALMITIS; EYE INFECTIONS, BACTERIAL; FEMALE; GLAUCOMA; HUMANS; INCIDENCE; INTRAOCULAR PRESSURE; LENS IMPLANTATION, INTRAOCULAR; MALE; MIDDLE AGED; MITOMYCIN; RETROSPECTIVE STUDIES; SURGICAL WOUND INFECTION; TRABECULECTOMY; TREATMENT OUTCOME; VISUAL ACUITY;

EID: 3142712908     PISSN: 10405488     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006324-200407000-00010     Document Type: Review

References (29)

1. Cohn H. Indications for trabeculectomy in open angle glaucoma. Bull Soc Belge Ophtalmol 1992;244:155-60.
2. Khalili MA, Diestelhorst M, Krieglstein GK. [Long-term follow-up of 700 trabeculectomies]. Klin Monatsbl Augenheilkd 2000;217:1-8; discussion 9.
3. D'Ermo F, Bonomi L, Doro D. A critical analysis of the long-term results of trabeculectomy. Am J Ophthalmol 1979;88:829-35.
4. Vesti E, Raitta C. A review of the outcome of trabeculectomy in open-angle glaucoma. Ophthalmic Surg Lasers 1997;28:128-32.
5. Lamping KA, Bellows AR, Hutchinson BT, Afran SI. Long-term evaluation of initial filtration surgery. Ophthalmology 1986;93:91-101.
6. Borisuth NS, Phillips B, Krupin T. The risk profile of glaucoma filtration surgery. Curr Opin Ophthalmol 1999;10:112-6.
7. Jampel HD. Effect of brief exposure to mitomycin C on viability and proliferation of cultured human Tenon's capsule fibroblasts. Ophthalmology 1992;99:1471-6.
8. Belyea DA, Dan JA, Stamper RL, Lieberman MF, Spencer WH. Late onset of sequential multifocal bleb leaks after glaucoma filtration surgery with 5-fluorouraol and mitomycin C. Am J Ophthalmol 1997;124:40-5.
9. Higginbotham EJ, Stevens RK, Musch DC, Karp KO, Lichter PR, Bergstrom TJ, Skuta GL. Bleb-related endophthalmitis after trabeculectomy with mitomycin C. Ophthalmology 1996;103:650-6.
10. Greenfield DS, Suner IJ, Miller MP, Kangas TA, Palmberg PF, Flynn HW Jr. Endophthalmitis after filtering surgery with mitomycin. Arch Ophthalmol 1996;114:943-9.
11. Bindlish R, Condon GP, Schlosser JD, D'Antonio J, Lauer KB, Lehrer R. Efficacy and safety of mitomycin-C in primary trabeculectomy: five-year follow-up. Ophthalmology 2002;109:1336-41.
12. Katz LJ, Cantor LB, Spaeth GL. Complications of surgery in glaucoma. Early and late bacterial endophthalmitis following glaucoma filtering surgery. Ophthalmology 1985;92:959-63.
13. Nuyts RM, Felten PC, Pels E, Langerhorst CT, Geijssen HC, Grossniklaus HE, Greve EL. Histopathologic effects of mitomycin C after trabeculectomy in human glaucomatous eyes with persistent hypotony. Am J Ophthalmol 1994;118:225-37.
14. Ashkenazi I, Melamed S, Avni I, Bartov E, Blumenthal M. Risk factors associated with late infection of filtering blebs and endophthalmitis. Ophthalmic Surg 1991;22:570-4.
15. Jampel HD, Quigley HA, Kerrigan-Baumrind LA, Melia BM, Friedman D, Barron Y. Risk factors for late-onset infection following glaucoma filtration surgery. Arch Ophthalmol 2001;119:1001-8.
16. Solomon A, Ticho U, Frucht-Pery J. Late-onset, bleb-associated endophthalmitis following glaucoma filtering surgery with or without antifibrotic agents. J Ocul Pharmacol Ther 1999;15:283-93.
17. Greenfield DS, Liebmann JM, Jee J, Ritch R. Late-onset bleb leaks after glaucoma filtering surgery. Arch Ophthalmol 1998;116:443-7.
18. Soltau JB, Rothman RF, Budenz DL, Greenfield DS, Feuer W, Liebmann JM, Ritch R. Risk factors for glaucoma filtering bleb infections. Arch Ophthalmol 2000;118:338-42.
19. Alfonso EC, Flynn HW Jr. Controversies in endophthalmitis prevention. The risk for emerging resistance to vancomycin. Arch Ophthalmol 1995;113:1369-70.
20. Kangas TA, Greenfield DS, Flynn HW Jr, Parrish RK 2nd, Palmberg P. Delayed-onset endophthalmitis associated with conjunctival filtering blebs. Ophthalmology 1997;104:746-52.
21. Song A, Scott IU, Flynn HW Jr, Budenz DL. Delayed-onset bleb-associated endophthalmitis: clinical features and visual acuity outcomes. Ophthalmology 2002;109:985-91.
22. Mandelbaum S, Forster RK, Gelender H, Culbertson W. Late onset endophthalmitis associated with filtering blebs. Ophthalmology 1985;92:964-72.
23. Brown RH, Yang LH, Walker SD, Lynch MG, Martinez LA, Wilson LA. Treatment of bleb infection after glaucoma surgery. Arch Ophthalmol 1994;112:57-61.
24. Donahue SP, Kowalski RP, Eller AW, DeVaro JM, Jewart BH. Empiric treatment of endophthalmitis. Are aminoglycosides necessary? Arch Ophthalmol 1994;112:45-7.
25. Campochiaro PA, Green WR. Toxicity of intravitreous ceftazidime in primate retina. Arch Ophthalmol 1992;110:1625-9.
26. Tabbara KF, Hyndiuk RA. Infections of the Eye. Boston: Little Brown, 1986.
27. Ciulla TA, Beck AD, Topping TM, Baker AS. Blebitis, early endophthalmitis, and late endophthalmitis after glaucoma-filtering surgery. Ophthalmology 1997;104:986-95.
28. Chen PP, Gedde SJ, Budenz DL, Parrish RK 2nd. Outpatient treatment of bleb infection. Arch Ophthalmol 1997;115:1124-8.
29. Mather R, Karenchak LM, Romanowski EG, Kowalski RP. Fourth generation fluoroquinolones: new weapons in the arsenal of ophthalmic antibiotics. Am J Ophthalmol 2002;133:463-6.